SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001513160-15-000019
Filing Date
2015-03-03
Accepted
2015-03-03 16:05:02
Documents
7
Period of Report
2015-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LION BIOTECHNOLOGIES CURRENT REPORT currentreport.htm 8-K 27875
2 UNDERWRITING AGREEMENT ex11.htm EX-1.1 367352
3 OPINION OF TROYGOULD PC ex51.htm EX-5.1 12732
4 PRESS RELEASE DATED FEBRUARY 25, 2015 ex991.htm EX-99.1 10530
5 PRESS RELEASE DATED FEBRUARY 26, 2015 ex992.htm EX-99.2 11216
6 PRESS RELEASE DATED MARCH 3, 2015 ex993.htm EX-99.3 10060
7 LOGO lionlogo.jpg GRAPHIC 596544
  Complete submission text file 0001513160-15-000019.txt   1263205
Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 15669003
SIC: 2836 Biological Products, (No Diagnostic Substances)